Encompass Compliance

Encompass Compliance EBIT per Share

EBIT per Share of Encompass Compliance (ENCC) as of Nov 3, 2026.

EBIT per Share

-0.00USD

YoY

139.67%

Last updated:

EBIT per Share of Encompass Compliance is 2025 -0.00 USD. EBIT per Share of Encompass Compliance was 2024 -0.00 USD. It decreases by 139.67% lower compared to the previous year.

The Encompass Compliance EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2013
0.00 USD
Jan 1, 2015
-0.00 USD
Jan 1, 2016
-0.00 USD
Jan 1, 2017
-0.00 USD
Jan 1, 2019
-0.00 USD
Jan 1, 2023
-0.00 USD
Jan 1, 2024
-0.00 USD
Jan 1, 2025
-0.00 USD
The Encompass Compliance EBIT per Share history
YEAREBIT per ShareYoY
-0.00USD+139.67%
-0.00USD+1,305.93%
-0.00USD-99.86%
-0.00USD-14.62%
-0.00USD+417.94%
-0.00USD-60.96%
-0.00USD-241.79%
0.00USD-102.53%
-0.03USD-98.39%
-1.95USD-2,742.19%
0.07USD-100.18%
-40.62USD-97.27%
-1,490.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Encompass Compliance Stock analysis

What does Encompass Compliance do? Encompass Compliance Corp provides workplace drug and alcohol testing compliance services through an annual subscription model. The company's offerings include the Drug Testing Compliance Matrix, statutes, regulations, and court decisions to help employers maintain compliance. It focuses on Medical Marijuana, Opiates, Synthetics, and other drugs and alcohol usage, delivering solutions like Risk Shield for creating core policies and real-time monitoring for testing orders. Customers are employers seeking to manage workplace drug and alcohol testing regulations. The firm offers training modules, consulting services, and Claims defense to support implementation and policy management. Its resource center provides up-to-date policies and guidance on evolving legal impacts. Encompass Compliance Corp's annual subscription service updates employers on regulatory changes, ensuring ongoing compliance with workplace testing laws. Risk Shield is a key product that allows employers to build core drug and alcohol policies while accounting for all applicable regulations. The company's services target organizations needing to navigate complex drug testing laws, particularly in sectors where Medical Marijuana, Opiates, and Synthetics are relevant. Training tools and real-time monitoring features enhance the value proposition for employers managing workplace safety. Encompass Compliance is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Encompass Compliance stock

On Eulerpool you can find the complete historical development of EBIT per Share Encompass Compliance since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Encompass Compliance

All Key Metrics — Encompass Compliance